How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

8,153 results for

Prevention of Vector-borne Infection

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Serological and molecular prevalence of canine vector-borne diseases (CVBDs) in Korea (PubMed)

prevalence rates of both "Ca. M. haematoparvum" and Mycoplasma haemocanis in dogs from Korea indicate that these organisms may be transmitted by vectors other than Rhipicephalus sanguineus because this tick species has rarely been found in Korea. This is the first nationwide survey for canine haemotropic mycoplasma infections in Korea.This study showed that the risk of exposure to major vector-borne diseases in dogs is quite high throughout all areas of South Korean Peninsula. Since achieving full (...) elimination of many pathogens causing CVBDs from infected animals is often impossible even when they are clinically cured, dogs once exposed to CVBDs can remain as lifetime reservoirs of disease for both other animals and humans in the close vicinity, and should therefore be treated with preventative medications to minimise the risk of pathogen transmission by the competent vectors.

Full Text available with Trip Pro

2017 Parasites & vectors

22. Tick-Pathogen Interactions and Vector Competence: Identification of Molecular Drivers for Tick-Borne Diseases (PubMed)

Tick-Pathogen Interactions and Vector Competence: Identification of Molecular Drivers for Tick-Borne Diseases Ticks and the pathogens they transmit constitute a growing burden for human and animal health worldwide. Vector competence is a component of vectorial capacity and depends on genetic determinants affecting the ability of a vector to transmit a pathogen. These determinants affect traits such as tick-host-pathogen and susceptibility to pathogen infection. Therefore, the elucidation (...) response to infect vectors and facilitate multiplication and transmission. Furthermore, some of these strategies may be used by pathogens to infect both tick and mammalian hosts. Identification of interactions that promote tick survival, spread, and pathogen transmission provides the opportunity to disrupt these interactions and lead to a reduction in tick burden and the prevalence of tick-borne diseases. Targeting some of the similar mechanisms used by the pathogens for infection and transmission

Full Text available with Trip Pro

2017 Frontiers in cellular and infection microbiology

23. Integrating Environmental Monitoring and Mosquito Surveillance to Predict Vector-borne Disease: Prospective Forecasts of a West Nile Virus Outbreak (PubMed)

Integrating Environmental Monitoring and Mosquito Surveillance to Predict Vector-borne Disease: Prospective Forecasts of a West Nile Virus Outbreak Predicting the timing and locations of future mosquito-borne disease outbreaks has the potential to improve the targeting of mosquito control and disease prevention efforts. Here, we present and evaluate prospective forecasts made prior to and during the 2016 West Nile virus (WNV) season in South Dakota, a hotspot for human WNV transmission (...) in the United States.We used a county-level logistic regression model to predict the weekly probability of human WNV case occurrence as a function of temperature, precipitation, and an index of mosquito infection status. The model was specified and fitted using historical data from 2004-2015 and was applied in 2016 to make short-term forecasts of human WNV cases in the upcoming week as well as whole-year forecasts of WNV cases throughout the entire transmission season. These predictions were evaluated

Full Text available with Trip Pro

2017 PLoS currents

24. Intestinal parasites and vector-borne pathogens in stray and free-roaming cats living in continental and insular Greece (PubMed)

cats living in areas of Greece under examination may be exposed to a plethora of internal parasites and vector-borne pathogens, some of them potentially able to infect humans. Therefore, epidemiological vigilance and appropriate control measures are crucial for the prevention and control of these infections and to minimize the risk of infection for people. (...) examined with different microscopic, serological and molecular assays aiming at evaluating the occurrence of intestinal parasites, and exposure to or presence of vector-borne infections. A total of 135 cats (90%) was positive for one or more parasites and/or pathogens transmitted by ectoparasites. Forty-four (29.3%) cats were positive for one single infection, while 91 (60.7%) for more than one pathogen. A high number of (n. 53) multiple infections caused by feline intestinal and vector-borne agents

Full Text available with Trip Pro

2017 PLoS neglected tropical diseases

25. Mosquitoes on a plane: Disinsection will not stop the spread of vector-borne pathogens, a simulation study (PubMed)

the incidental transportation of infected mosquitoes. Thus, while disinsection may serve a role in preventing the spread of vector species and other invasive insects, it is unlikely to impact the spread of mosquito-borne pathogens. (...) Mosquitoes on a plane: Disinsection will not stop the spread of vector-borne pathogens, a simulation study Mosquito-borne diseases are increasingly being recognized as global threats, with increased air travel accelerating their occurrence in travelers and their spread to new locations. Since the early days of aviation, concern over the possible transportation of infected mosquitoes has led to recommendations to disinsect aircraft. Despite rare reports of mosquitoes, most likely transported

Full Text available with Trip Pro

2017 PLoS neglected tropical diseases

26. Vaccine-preventable Infections and Immunization in Multiple Sclerosis

Vaccine-preventable Infections and Immunization in Multiple Sclerosis 1 Practice guideline update: Vaccine-preventable infections and immunization in multiple sclerosis Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology Mauricio F. Farez, MD, MPH, 1 Jorge Correale, MD, 1,2 Melissa J. Armstrong, MD, MSc, 3 Alexander Rae-Grant, MD, 4 David Gloss, MD, 5 Diane Donley, MD, 6 Yolanda Holler-Managan, MD, 7 Norman J. Kachuck, MD, 8 (...) with their patients and explore patients’ opinions, preferences, and questions. Clinicians should recommend that patients with MS follow all local vaccine standards unless there are specific contraindications and weigh local vaccine-preventable disease risks when counseling patients. Clinicians should recommend that patients with MS receive the influenza vaccination annually. Clinicians should counsel patients with MS about infection risks associated with specific immunosuppressive/immunomodulating (ISIM

2019 American Academy of Neurology

27. Investigations by the Institut Hospitalo-Universitaire Méditerranée Infection of food and food-borne infections in the Mediterranean Basin and in sub-Saharan Africa (PubMed)

and therefore at improving the understanding, diagnosis, prevention and control of these infections. Investigations were conducted in the Mediterranean area and in sub-Saharan Africa on more than 15 food-borne agents, 17 food products and 14 antibiotic resistance-associated genes. Multiple sources, including unexpected ones, and pathogens, including emerging ones, were involved. Travelling in developing countries and zoonoses are major contributors to food-borne infections, while food-borne transmission (...) Investigations by the Institut Hospitalo-Universitaire Méditerranée Infection of food and food-borne infections in the Mediterranean Basin and in sub-Saharan Africa Food-borne infections are major causes of public health concern in developing and developed countries. During the past decade, the Institut Hospitalo-Universitaire Méditerranée Infection has conducted or been involved in multiple investigations that aimed at identifying the sources and strains responsible for food-borne diseases

Full Text available with Trip Pro

2018 New Microbes and New Infections

28. Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment. (PubMed)

Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment. Tick-borne encephalitis (TBE) is an emerging health threat that is spreading in many parts of Europe. The mix of socio-economical, ecological and climatic factors as well as the presence of more susceptible hosts is actively contributing to the increasing number of TBE reported cases. TBE is an important cause of central nervous system (CNS) infection that can result in long-term (...) vaccination to prevent disease-related morbidity and mortality. Due to expanding proportion of subject possibly exposed to TBE (and new populations such as: unaware travellers to TBE-endemic areas and immunocompromised patients), we performed a comprehensive review of TBE epidemiology, clinical presentation, current available diagnostic tools and treatment.Copyright © 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

2019 European journal of internal medicine

29. Oral Immunization with OspC Does Not Prevent Tick-Borne Borrelia burgdorferi Infection (PubMed)

Oral Immunization with OspC Does Not Prevent Tick-Borne Borrelia burgdorferi Infection Oral vaccination strategies are of interest to prevent transmission of Lyme disease as they can be used to deliver vaccines to humans, pets, and to natural wildlife reservoir hosts of Borrelia burgdorferi. We developed a number of oral vaccines based in E. coli expressing recombinant OspC type K, OspB, BBK32 from B. burgdorferi, and Salp25, Salp15 from Ixodes scapularis. Of the five immunogenic candidates (...) only OspC induced significant levels of antigen-specific IgG and IgA when administered to mice via the oral route. Antibodies to OspC did not prevent dissemination of B. burgdorferi as determined by the presence of spirochetes in ear, heart and bladder tissues four weeks after challenge. Next generation sequencing of genomic DNA from ticks identified multiple phyletic types of B. burgdorferi OspC (A, D, E, F, I, J, K, M, Q, T, X) in nymphs that engorged on vaccinated mice. PCR amplification of OspC

Full Text available with Trip Pro

2016 PloS one

30. Developmental follow-up of children and young people born preterm

that they are likely to be anxious about caring for their baby after discharge. This may relate to: interaction with the baby managing feeding patterns of sleeping physical positioning of the baby, including safe sleeping impact on day-to-day living, such as social isolation because of fear of infection. 1.1.10 Involve the social support networks (which may include partners, grandparents Developmental follow-up of children and young people born preterm (NG72) © NICE 2019. All rights reserved. Subject to Notice (...) Developmental follow-up of children and young people born preterm De Dev velopmental follow-up of children and elopmental follow-up of children and y young people born preterm oung people born preterm NICE guideline Published: 9 August 2017 nice.org.uk/guidance/ng72 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view

2017 National Institute for Health and Clinical Excellence - Clinical Guidelines

31. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers. (PubMed)

Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers. Maternal anti-viral treatment prevents mother-to-infant transmission of hepatitis B virus (HBV), but the role of neonatal viremia on subsequent HBV infection is not clear.To investigate the effect of maternal anti-viral treatment on neonatal serum HBV DNA and hepatitis B surface antigen (HBsAg) in infants born to highly viremic (...) mothers and the roles of neonatal markers in predicting chronic HBV infection in children.Serum HBV DNA and HBsAg were tested in children. Of the 201 pregnant mothers, 110 received tenofovir during the third trimester. Chronic infection in children was defined by HBsAg seropositivity at 6 or 12 months lasting more than 6 months.The maternal HBV viral loads from baseline to delivery were 8.25 ± 0.48 to 4.29 ± 0.98 log10  IU/mL; and 8.29 ± 0.49 to 8.12 ± 0.68 log10  IU/mL in the tenofovir and control

2019 Alimentary Pharmacology & Therapeutics

32. Childhood MMR vaccination and the incidence rate of measles infection: a ten year longitudinal cohort study of American children born in the 1990s. (PubMed)

Childhood MMR vaccination and the incidence rate of measles infection: a ten year longitudinal cohort study of American children born in the 1990s. Measles (rubeola) is a highly contagious disease with significant morbidity/mortality. Measles-Mumps-Rubella (MMR) is a live-attenuated vaccine used in the United States (US) since the early 1970s to prevent measles infection. This retrospective longitudinal cohort study examined childhood MMR vaccination effectiveness (VE) on preventing diagnosed (...) as compared to the unvaccinated cohort. VE = 80% among younger MMR recipients (12-15 months), whereas VE = 90% among older MMR recipients (16-20 months) as compared to the unvaccinated cohort.Routine childhood MMR vaccination significantly reduced the incidence rate of childhood measles infections, and the VE was greater in the older recipients (16-20 months) than in the younger recipients (12-15 months).

2019 BMC Pediatrics

33. Management of Blood Borne Viruses within the Haemodialysis Unit

of Health. Good Practice Guidelines for Renal Dialysis/Transplantation Units. Prevention and control of blood-borne virus infection. 2002. 4 Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005;18:52-61. Renal Association Clinical Practice Guideline – Blood Borne Viruses – June 2019 6 5 All patients receiving renal replacement therapy in the United Kingdom 2015. In: NEPHRON 2017;137 (suppl1) UK Renal (...) of hepatitis C virus between hemodialysis patients sharing the same machine. Infection Control & Hospital Epidemiology 2004;25:609-611. 20 Stragier A, Jadoul M. Should dialysis machines be disinfected between patients' shifts? Edtna-Erca Journal 2003;29:73-76. Renal Association Clinical Practice Guideline – Blood Borne Viruses – June 2019 7 21 Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic

2019 Renal Association

34. Vector Borne Disease

Vector Borne Disease Vector Borne Disease Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Vector Borne Disease Vector Borne Disease (...) Aka: Vector Borne Disease , Vector-Borne Infection , Mosquito-Borne Disease , Mosquito-Borne Illness , Mosquito Borne Infection From Related Chapters II. Epidemiology Vector Borne Disease causes 17% of worldwide infections (in 2016) III. Trasmission: U.S. Vector borne illness es Dirofilariasis (Puerto Rico, Texas, Florida, Hawaii) es California (including LaCrosse) Saint Louis Eastern equine Western equine (most common vector-borne virus in U.S. as of 2016) Ticks ( microti) (arenavirus

2018 FP Notebook

35. Non-vector-borne transmission of Zika virus: A systematic review. (PubMed)

Non-vector-borne transmission of Zika virus: A systematic review. Increasing numbers of confirmed cases of Zika virus (ZIKV) infection resulting from non-mosquito-borne transmission have been reported.We performed a systematic literature review (PRISMA guidelines) on intrauterine, intrapartum, sexual and animal bite ZIKV transmission. The presence of the virus in breast milk, urine, saliva and blood transfusions was also reviewed.The search resulted in 285 papers of possible relevance, of which (...) and urine and data on saliva, animal bites, transplantation, needlestick injury and laboratory work are inconclusive.Our systematic analysis shows that non-vector-borne ZIKV transmission plays a role in the spread of ZIKV and has great societal impact. It has important public health implications for the prevention and control of ZIKV globally and will be a basis for policy and further research.Copyright © 2016 Elsevier Ltd. All rights reserved.

2016 Travel medicine and infectious disease

36. Control of Vector-Borne Human Parasitic Diseases (PubMed)

Control of Vector-Borne Human Parasitic Diseases 28090535 2017 01 30 2018 11 13 2314-6141 2016 2016 BioMed research international Biomed Res Int Control of Vector-Borne Human Parasitic Diseases. 1014805 10.1155/2016/1014805 Genta Fernando A FA 0000-0001-9558-1116 Oswaldo Cruz Institute-Oswaldo Cruz Foundation (IOC-FIOCRUZ), Av. Brasil 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology for Molecular Entomology (INCT-EM), Av. Carlos Chagas Filho (...) Parasitologia Médica, Global Health & Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, Rua da Junqueira 100, 1349-008 Lisbon, Portugal. Gomes Bruno B 0000-0003-3877-2359 Department of Vector Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK. eng Editorial 2016 12 20 United States Biomed Res Int 101600173 IM Animals Arthropod Vectors Humans Parasitic Diseases epidemiology prevention & control transmission 2016 10 03 2016

Full Text available with Trip Pro

2016 BioMed research international

37. PCR diagnosis of tick-borne pathogens in Maharashtra state, India indicates fitness cost associated with carrier infections is greater for crossbreed than native cattle breeds. (PubMed)

PCR diagnosis of tick-borne pathogens in Maharashtra state, India indicates fitness cost associated with carrier infections is greater for crossbreed than native cattle breeds. Tick-borne pathogens (TBP) are responsible for significant economic losses to cattle production, globally. This is particularly true in countries like India where TBP constrain rearing of high yielding Bos taurus, as they show susceptibility to acute tick borne disease (TBD), most notably tropical theileriosis caused (...) by Theileria annulata. This has led to a programme of cross breeding Bos taurus (Holstein-Friesian or Jersey) with native Bos indicus (numerous) breeds to generate cattle that are more resistant to disease. However, the cost to fitness of subclinical carrier infection in crossbreeds relative to native breeds is unknown, but could represent a significant hidden economic cost. In this study, a total of 1052 bovine blood samples, together with associated data on host type, sex and body score, were collected

Full Text available with Trip Pro

2017 PLoS ONE

38. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats. (PubMed)

Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats. We previously developed a potent candidate vaccine against bovine brucellosis caused by Brucella abortus using the influenza viral vector expressing Brucella Omp16 and L7/L12 proteins (Flu-BA). Our success in the Flu-BA vaccine trial in cattle and results of a pilot study in non-pregnant small ruminants prompted us (...) in the current study to test its efficacy against B. melitensis infection in pregnant sheep and goats. In this study, we improved the Flu-BA vaccine formulation and immunization method to achieve maximum efficacy and safety. The Flu-BA vaccine formulation had two additional proteins Omp19 and SOD, and administered thrice with 20% Montanide Gel01 adjuvant, simultaneously by both subcutaneous and conjunctival routes at 21 days intervals in pregnant sheep and goats. At 42 days post-vaccination (DPV) we detected

Full Text available with Trip Pro

2017 PLoS ONE

39. Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups

Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups GUIDELINE: PREVENTIVE CHEMOTHERAPY TO CONTROL SOIL-TRANSMITTED HELMINTH INFECTIONS IN AT-RISK POPULATION GROUPS 2017GUIDELINE: PREVENTIVE CHEMOTHERAPY TO CONTROL SOIL-TRANSMITTED HELMINTH INFECTIONS IN AT-RISK POPULATION GROUPSWHO Library Cataloguing-in-Publication Data Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups ISBN 978-92-4 (...) and authentic edition” . Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Guideline: preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO . Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights

2017 World Health Organisation Guidelines

40. Prevention, Diagnosis & Management of infective endocarditis

Prevention, Diagnosis & Management of infective endocarditis CLINICAL PRACTICE GUIDELINES FOR THE PREVENTION, DIAGNOSIS & MANAGEMENT OF INFECTIVE ENDOCARDITISPUBLISHED BY: Clinical Practice Guidelines (CPG) Secretariat c/o Health Technology Assessment (HTA) Unit Medical Development Division Ministry of Health Malaysia 4 th floor, Block E1, Parcel E 62590 Putrajaya COPYRIGHT The owners of this publication are the National Heart Association of Malaysia (NHAM) and the Academy of Medicine Malaysia (...) committee, a multidisciplinary team will be formed for the specific purpose of updating this CPG.TABLE OF CONTENTS FORWARD BY THE DIRECTOR GENERAL OF HEALTH 4 INFECTIVE ENDOCARDITIS CLINICAL PRACTICE GUIDELINES EXPERT PANEL 5 EXTERNAL REVIEWERS 7 GRADES OF RECOMMENDATION AND LEVELS OF EVIDENCE 10 RATIONALE AND PROCESS OF THE INFECTIVE ENDOCARDITIS GUIDELINES DEVELOPMENT 11 SUMMARY OF THE CLINICAL PRACTICE GUIDELINES FOR THE PREVENTION, DIAGNOSIS AND MANAGEMENT OF INFECTIVE ENDOCARDITIS 15 1.0

2017 Ministry of Health, Malaysia

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>